This is the authors' abstract. We don't add key points for this paper.
OBJECTIVE: We hypothesized that serum uromodulin levels (sUMOD) and the uromodulin rs4293393 T > C polymorphism could aid in risk stratification for kidney injury (KI) in patients with a congenital solitary functioning kidney (CSFK), serving as markers of nephron mass. We tested this hypothesis in a cohort study of 56 CSFK patients followed from birth to adulthood. The rs4293393 polymorphism was genotyped using the TaqMan assay. Serum uromodulin was measured at last follow-up using ELISA. KI was defined by estimated glomerular filtration rate < 90 ml/min/1.73m2 and/or hypertension and/or proteinuria. RESULTS: Over a mean follow-up of 21.1years(range:18-33), 15 patients (26.8%) developed KI. Genotypes were TT (62.5%) and TC (37.5%). Higher sUMOD levels in early adulthood were linked to kidney length(KL) > 2SDS in early-life and absence of the C allele. Lower sUMOD levels were associated with KI and its components. Kaplan-Meier analysis showed 100% KI-free survival at 33years in patients with early KL > 2SDS. Survival dropped to 62.4% in those without early KL > 2SDS and wild-type genotype, and to 0% by 26years in C allele carriers (p = 0.001). The hazard ratio for KI in C allele carriers was 5.1(95%confidence interval:1.6-16.2;p = 0.006). Therefore, early-life kidney ultrasound, combined with rs4293393 genotyping might improve risk stratification for KI in patients with CSFK.
No takes yet. Share an insight, caveat, or question.
Guarino et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: